在神经母细胞瘤中,与ATRX框架内删除相比,与ATRX功能丧失相比,对视网膜酸的不同染色质可访问性反应

Federica Lorenzi1, Matthew Shipley2, Luke Deane2

  • 1Developmental Oncology Group, Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5AG, United Kingdom; Neural Stem Cell Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, United Kingdom.

Neoplasia (New York, N.Y.)
|December 11, 2025
PubMed
概括

神经母细胞瘤 (一种儿童癌症) 的差异化治疗反应取决于ATRX变化的类型. 功能丧失的ATRX变化阻止了网膜酸 (RA) 适当的基因调节,影响了治疗的有效性.